R
Redx Pharma PLC
LSE:REDX
Redx Pharma PLC
LSE:REDX
Price:
15 GBX
31.58%
Market Closed
Updated:
May 28, 2024
Redx Pharma PLC
EPS (Diluted)
|
Redx Pharma PLC
EPS (Diluted) Peer Comparison
Comparables:
GSK
AZN
INDV
HIK
DPH
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
R
|
Redx Pharma PLC
LSE:REDX
|
EPS (Diluted)
£0
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
EPS (Diluted)
£1
|
CAGR 3-Years
-6%
|
CAGR 5-Years
7%
|
CAGR 10-Years
0%
|
|
|
AstraZeneca PLC
LSE:AZN
|
EPS (Diluted)
$4
|
CAGR 3-Years
10%
|
CAGR 5-Years
16%
|
CAGR 10-Years
10%
|
|
|
Indivior PLC
LSE:INDV
|
EPS (Diluted)
$0
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
N/A
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
EPS (Diluted)
$0
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-2%
|
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
EPS (Diluted)
£0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Redx Pharma PLC's EPS (Diluted)?
EPS (Diluted)
-0.1
GBP
-0.1
GBP
Based on the financial report for Sep 30, 2023, Redx Pharma PLC's EPS (Diluted) amounts to -0.1 GBP.
What is Redx Pharma PLC's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-7%
-7%
Over the last year, the EPS (Diluted) growth was -67%. The average annual EPS (Diluted) growth rates for Redx Pharma PLC have been -26% over the past three years , -7% over the past five years .
You don't have any saved screeners yet
